ACME GROUP of companies are professionally managed pharmaceutical companies, manufacturing wide range of Human Medicinal formulations like Small Volume Parenterals, Tablets, Oral Powders in Sachets,ORS, Artificial & Natural Sweeteners as well as Veterinary Boluses and Powders. The company was incorporated in the year 1985. The group companies are actively involved in the field of contract manufacturing since almost last three decades.
Details of Manufacturing Facilities:
1. ACME PHARMACEUTICALS PVT. LTD - Manuacturer of General Liquid Injectables in Glass Ampoules & Vials
(WHO GMP & PPB-Kenya Approved)
Site Address : PF 61&62, sanand II industrial area, GIDC, Sanand, Dist. Ahmedabad, Gujarat, India
Registratrion in process: Ethiopia-FMHACA, Nigeria-NAFDAC, Philippines FDA, MoH Yemen, MoH IRAQ/KMCA., TFDA-Tanzania, NDA-Uganda etc.Future Target: PICS & EU GMP
Kindly view video presentation from this link:
2. ACME LIFE TECH-LLP (WHO GMP approved) Plot no. 103,104,105 epip phase I,Jharmajri, baddi, H.P., India
Registratrion in process: Philippines , Yemen,Nigeria, PANAMA, CAMBODIA, MYANMAR, UZBEKISTAN, TAJIKISTAN, BELARUS, GUATEMALA etc.
Future Target: PICS & EU GMP
3. ACME DIET CARE PVT. LTD - ORS & Food Products
(WHO GMP , ISO and HACCP Approved) 14, Panchratna Industrial Estate, Changodar, Dist. Ahmedabad
4. SHANKU'S PHARMACEUTICALS - APIs & Advanced Intermediate Products
(WHO GMP Approved), Plot No 9, 10, 11 Milan Industrial Estate, Vadsar Road, Santej, Ta: Kalol,Dist: Gandhinagar - 382721, Gujarat, India.
Shanku's Pharmaceuticals is for a decade, engaged in manufacture and research based at Ahmedabad. Our portfolio includes APIs and Advanced
intermediates, duly supported by in-house R&D team.
Biophore, an established pharmaceutical company is engaged in the development and manufacture of niche pharmaceutical products for generic industry.Within a decade since inception in 2007, Biophore has emerged as a trusted partner in generic industry across US, Europe and other regulated markets. Biophore's product range is diverse and balanced with NCE, Branded products and grandfather products.
Biophore's portfolio spread across 30 therapeutic segments, is specialized in development and manufacture of pharmaceutical actives for Oncology medications, Contrast and Diagnostic media.
For updated list of products, send an email to [email protected]
Brooks Laboratories Ltd was established in 2002 and maintains its strong presence in the Pharmaceutical industry as a Contract Manufacturing Company since its inception. Brooks Laboratories Ltd is a Research and Development driven Pharmaceutical manufacturing company. In last 6 years company has successfully established itself as a reputed Contract Manufacturing company for generic products in Injectables and Amoxiillin + Clavulanic Acid range of Tablets and Dry Syrups. Brooks has recently commissioned a Brand New Dedicated Facility for Carbapenem Injections at Baroda, India, with a huge capacity of 50 million vials per annum. The New Carbapenem Facility at Baroda will also manufacture Lyophilized Carbapenem injections like Ertapenem. The new Dedicated Carbapenem Plant has been designed for Development and Supply of Injections for Europe, USA, Canada, Australia, South Africa and other Regulated Markets and also do Contract Manufacturing for Quality Conscious Pharmaceutical companies for Regulated and Semi Regulated Markets. Brooks can as well provide interested customers with ANDAs and Dossiers in CTD formats. The new Plant at Baroda has good capacity to cater to big markets of USA, Europe etc. The entire new plant of Carbapenems at Baroda has been designed as per the cGMP requirements of US-FDA, European GMP standards and WHO standards. The Carbapenem plant is scheduled for a European GMP audit and certification in August '2017. Interested parties for Carbapenems and other injections can contact us - [email protected]
5th ranked Indian Pharmaceutical Company, having own R&D, BE Centre, API,
Finished Dosage manufacturing sites, approved by USFDA,MHRA etc. Have
CVS/CNS/Anti-Diabetic/Anti-HIV/AntiTB/Anti Asthmatic/Anti Malarial products with
presence across 110 countries and subsidiaries in USA, UK, Spain, South Africa,
Ukraine and Kazak. We offer: MA of EU,Out-licensing US/EUCTD with FDF/API
Morepen Laboratories Limited is a 33 year old company manufacturing APIs (Loratadine, Desloratadine, Atorvastatin, Montelukast, Rosuvastatin, Fexofenadine, Olmesartan, Sitagliptin Linagliptin, Saxagliptin, Dapagliflozin, Canagliflozin etc.) at its world class manufacturing facilities, approved by USFDA, European & other regulatory authorities. Morepen adheres to latest cGMP standards, has DMF/CoS/Tech.Packs, exports to more than 60 countries.
Nutra is a pioneer manufacturer of unique niche APIs and have 3 COS Approval, 1 MHRA Approval and 2 Korean FDA Approvals. We are also simultaneously working on USFDA, ANVISA and Chinese SFDA for our key product Olmesartan Medoxomil. We are leaders in Warfarin Sodium, Tetracaine HCL and Olmesartan along with upcoming gliptin molecules. We have WHO GMP and ISO 9001:2008 certification and focus on stringent quality standards and continously upgrade our manufacturing technology to upkeep the competitive industry. We have crossed a revenue of USD 15Mn and have over 160 Employees and are aiming to be Leading Niche Manufacturer.
Zhejiang Ausun Pharmaceutical Co Ltd, established in 2009 and covering an area of 70,000 square meters, is located in Zhejiang Chemical Materials Base, Linhai Zone. Ausun Pharma specializes in the development and manufacturing of formulations, APIs, pharmaceutical intermediates and fine chemicals,and plans to develop special varieties of medical products with high added-value, low energy consumption, low pollution and own intellectual property rights according to the market need. Honesty & win-win is our basic principle. Ausun Pharm. is your reliable Strategic Partner!
Zhejiang Guobang Pharmaceutical Co Ltd is one of the leading manufacturers of pharmaceutical in China, including API manufacturing, finished products manufacturing, and proprietary new drug development. Guobang devotes itself to developing and producing quinolones and macrolides and now we are starting the project of cephalosporins.
Also Guobang has the biggest manufacturing output of Ciprofloxacin and Azithromycin, Roxithromycin, Clarithromycin in the world. Guobang would like to cooperate with pharmaceutical companies all over the world and will consistently supply high quality intermediates, APIs, finished products and custom chemicals to valuable customers.
Zhejiang Peptites Biotech Co Ltd (ZPC) is one of the largest synthetic manufacturers in China. ZPC started with its R&D Center, named Hangzhou Peptide Biochem Co.,Ltd, which focuses on researching and developing new types of polypeptides.
ZPC has an extensive portfolio of manufacturing equipment installed and qualified to produce cGMP-grade peptides in every stage: fully automated peptide synthesis system, isolation and purification system, lyophilization system.
With the lasted expansion, more than 160,000 fts are available for manufacturing requirement. And the solid-phase synthesis process line we established is suitable for large-scale production. So we can handle the API development from milligram to 100s of kilogram scale.The delivery time of the custom peptide can be controlled at 2-3 weeks.